Clover Health Investments, Corp. (CLOV) Stock Forecast
CLOV analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 4 analysts
- Price target
- $5.38 average of analyst targets
- Upside to target
- +20.0% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $-0.01
- 52-week range
- $1.70 – $5.41
CLOV analyst ratings
4 analystsNumber of analysts at each rating.
CLOV price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CLOV earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.01 | $0.01 | $0.01 | $0.00 | +203.0% | 1 |
| Current fiscal year (2026) | $0.14 | $0.14 | $0.14 | $0.04 | +259.0% | 1 |
| Next fiscal year (2027) | $0.15 | $0.15 | $0.15 | $0.14 | +7.1% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CLOV revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $738.2M | $727.6M | $744.4M | +48.6% | 3 |
| Current fiscal year (2026) | $2.95B | $2.94B | $2.96B | +53.5% | 4 |
| Next fiscal year (2027) | $3.53B | $3.41B | $3.61B | +19.3% | 4 |
CLOV EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CLOV revenue: reported and forecast
CLOV EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | — | 0 up · 1 down |
| Current fiscal year (2026) | $0.09 | $0.09 | $0.14 | $0.14 | $0.14 | +55.6% | 0 up · 1 down |
| Next fiscal year (2027) | $0.10 | $0.10 | $0.15 | $0.15 | $0.15 | +50.0% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CLOV earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CLOV beat in 11 of 12.
What analysts expect from CLOV
4 analysts cover Clover Health Investments; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $5.38, 20.0% above the latest close of $4.48. Analysts expect earnings of $0.14 per share for 2026, +259.0% from a year earlier. For 2027 the average estimate is $0.15 per share on revenue of $3.5 billion. Clover Health Investments beat the EPS estimate in 11 of the last 12 quarters.
Related: CLOV income statement, CLOV key metrics, CLOV chart. See the CLOV stock overview for the latest quote and news.
CLOV forecast FAQ
What is Clover Health Investments's price target?
The average analyst price target for Clover Health Investments is $5.38, 20.0% above the latest close of $4.48.
Is Clover Health Investments a buy, hold or sell?
Of 4 analysts covering Clover Health Investments, 2 rate it a strong buy, 0 a buy, 2 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Clover Health Investments's EPS forecast?
Analysts forecast $0.14 per share for 2026 (range $0.14 to $0.14); for 2027 the estimate is $0.15.
What is Clover Health Investments's revenue forecast?
The average revenue estimate for 2026 is $3.0 billion, growth of 53.5%; for 2027 it is $3.5 billion.
When does Clover Health Investments report earnings?
Clover Health Investments is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes; the EPS estimate is $-0.01.
Does Clover Health Investments usually beat earnings estimates?
Clover Health Investments reported EPS at or above the analyst estimate in 11 of the last 12 quarters.